Low dose cyclosporine in early rheumatoid arthritis: Effective and safe after two years of therapy when compared with chloroquine

Scandinavian Journal of Rheumatology

Volumn 25, Issue 5, 1996, Pages 307-316

  Van Den Borne, B E E M ^a   Landewe R B M ^b   Goei The, H S ^b   Breedveld, F C ^a   Dijkmans, B A C ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Rheumatology   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chloroquine; Cyclosporine; Follow up; Rheumatoid arthritis; Therapy

Indexed keywords

CHLOROQUINE; CYCLOSPORIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

EID: 0029903564     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609104063     Document Type: Article

References (28)

1. Weinblatt ME, Maier AL. Treatment of rheumatoid arthritis. Arthritis Care Res 1989; 2: S23-S32.
2. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE. Antirheumatic drugs: a proposed new classification. Arthritis Rheum 1993; 36: 336-9.
3. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: 11. Second line drugs and prednisone. J Rheumatol 1992; 19: 1885-94.
4. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-38.
5. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35: 729-35.
6. van Rijthoven AW, Dijkmans BA, Goei The HS, Hermans J, Montnor-Beckers ZL, Jacobs PC et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Ann Rheum Dis 1986; 45: 726-31.
7. van Rijthoven AW, Dijkmans BA, Goei The HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, et al. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. J Rheumatol 1991; 18: 815-20.
8. Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 1988; 47: 127-33.
9. Forre O, Bjerkhoel F, Salvesen CF, Berg KJ, Rugstad HE, Saelid G, et al. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 1987; 30: 88-92.
10. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-5.
11. Landewe RB, Goei The HS, van Rijthoven AW, Breedveld FC, Dijkmans BA. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994; 37: 637-43.
12. Dijkmans BA, van Rijthoven AW, Goei The HS, MontnorBeckers ZL, Jacobs PC, Cats A. Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis. Eur J Clin Pharmacol 1987; 31: 541-5.
13. Madhok R, Torley HI, Capell HA. A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis. J Rheumatol 1991; 18: 1485-9.
14. van Rijthoven AW, Dijkmans BA, Goei The HS, Boers M, Cats A. Longterm cyclosporine therapy in rheumatoid arthritis. J Rheumatol 1991; 18: 19-23.
15. An international consensus report: the use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993; 32 (Suppl 1): 1-3.
16. Boers M, Dijkmans BA, van Rijthoven AW, Goei The HS, Cats A. Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis. J Rheumatol 1990; 17: 38-42.
17. Landewé RB, Dijkmans BA, van der Woude FJ, Breedveld FC, Mihatsch MJ, Bruijn JA. Long-term low-dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. J Rheumatol 1996; 23: 61-4.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
20. Ritchie DM, Boyle JA, Mclnnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393-406.
21. Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984; 3: 305-9.
22. Paulus HE, Egger MJ, Ward JR, Williams HJ. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum 1990; 33: 477-84.
23. The epidemiology of chronic rheumatism. Vol 2. Atlas of standard radiographs of arthritis, Oxford; Blackwell Scientific Publications, 1963.
24. Forre O, Bjerkhoel F. Kjeldsen-Kragh J, Ostensen H, Astor T, Boe E, et al. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine - Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 1994; 37: 1506-12.
25. Berg KJ, Forre O, Djoseland O, Mikkelsen M, Narverud J, Rugstad HE. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 1989; 31: 232-8.
26. Feutren G, Mihatsch MJ. Risk factors for cyclosporineinduced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 1992; 326: 1654-60.
27. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20: 759-71.
28. Riou B, Barriot P, Rimailho A, Baud FJ. Treatment of severe chloroquine poisoning. N Engl J Med 1988; 318: 1-6.